01 AI-Based Navigation Strengthens Real-Time Procedural Guidance The market is shifting toward artificial intelligence systems that assist clinicians during minimally invasive procedures. These tools can identify medical devices, improve image quality, reduce visual noise, and provide guidance while treatment is underway. Integrating AI directly into angiography platforms helps clinical teams interpret complex anatomy without repeatedly stopping the procedure for manual measurements. Manufacturers are also combining two-dimensional and three-dimensional imaging with automated workflow functions to support faster planning and device positioning. Consequently, competition is increasingly based on software intelligence, real-time visualization, and the ability to upgrade existing interventional rooms with new digital capabilities. In March 2026, Philips received U.S. FDA clearance for DeviceGuide, an AI solution integrated with Azurion for real-time guidance during heart-valve repair procedures.
01 Expanding Minimally Invasive Care Increases System Demand Hospitals are adopting image-guided therapy systems to expand minimally invasive treatment for cardiovascular disease, stroke, and cancer. These platforms allow clinicians to view anatomy and guide instruments during procedures through small access points. This can support more precise treatment while reducing the need for conventional open surgery in suitable cases. Demand rises when governments develop specialized referral networks because participating hospitals require angiography equipment, clinical software, servicing, and staff training. Wider availability in regional hospitals also helps move advanced procedures beyond large urban medical centres. Healthcare infrastructure programs are therefore creating long-term purchasing opportunities for complete image-guided treatment rooms.
01 High Equipment and Infrastructure Costs Restrict Hospital Purchases Image-guided therapy systems require substantial investment in equipment, room construction, radiation shielding, software, and ongoing maintenance. Hospitals must also purchase compatible tables, displays, injectors, and clinical devices before beginning procedures. These costs make adoption difficult for smaller facilities with limited capital budgets or low patient volumes. Imported components and currency movements can further increase procurement expenses, while service contracts create continuing financial commitments. Long approval and installation periods may delay returns on investment. Consequently, many hospitals continue using older imaging rooms or prioritize essential diagnostic equipment, restricting demand for advanced therapy platforms despite their wider clinical capabilities.
01 Handheld Robotic Guidance Expands Access Beyond Specialized Suites Compact robotic guidance systems are creating opportunities to extend image-guided procedures into more departments and outpatient settings. Conventional interventional rooms require fixed imaging equipment and highly specialized operators, limiting access in smaller hospitals. Handheld platforms combining ultrasound, robotics, and navigation software can guide instrument placement using equipment already available in many facilities. This creates demand for portable systems in vascular access, pain management, urology, and other procedure areas. Suppliers offering simple controls, compatible ultrasound connections, and structured training can reach customers unable to build full angiography suites. Portable guidance may therefore establish a new product category alongside large fixed installations.
01 Specialist Training Requirements Slow Effective System Utilization Advanced imaging equipment cannot improve procedural capacity unless hospitals have clinicians and technicians trained to operate it safely. Users must understand imaging angles, navigation software, equipment movement, radiation management, and procedure-specific workflows. Training becomes more complex when hospitals combine angiography, ultrasound, three-dimensional imaging, and robotic functions in one room. Staff shortages can leave expensive systems underused and increase dependence on manufacturer support. Vendors must therefore provide simulation, continuing education, and application specialists alongside equipment installation. Ensuring consistent skills across different hospitals remains difficult, particularly when systems are deployed rapidly through large regional healthcare programs.
November 2025 Siemens Healthineers presented Optiq AI, an AI-powered imaging chain developed to provide clearer low-dose images during image-guided procedures. It was introduced for three new Artis interventional imaging platforms.
July 2025 Philips and Indonesia’s Ministry of Health announced a multiyear program to install Azurion image-guided therapy systems across all 38 Indonesian provinces, expanding access to cardiac, stroke, and cancer treatments.
March 2025 Leiden University Medical Center opened its Image-Guided Therapy Center using Philips Azurion interventional systems, AngioCT Spectral, and Zenition 70 C-arms. The facility was designed to treat approximately 50–60 patients daily.